We provided evidence that the loss of H3-H4 histone chaperones rescued cell division failures in C. elegans bearing the H2BE76K mutation, suggesting that H3-H4 histone chaperones may be promising therapeutic targets for treating cancers resulting from dysfunctional H2B oncohistone mutations. This evidence concerns the gene H2BC21 and cancer.